CD177, MYBL2, and RRM2 Are Potential Biomarkers for Musculoskeletal Infections
CD177, MYBL2, and RRM2 proteins in blood samples may serve as novel biomarkers for diagnosing and monitoring treatment response in musculoskeletal infections.
Authors
- Irvin Oh (ORCID: https://orcid.org/0000-0002-2648-5849)
- Matthew D. Riedel (ORCID: https://orcid.org/0000-0001-6640-7071)
- Taiwo Samuel Agidigbi
- Brianna Fram (ORCID: https://orcid.org/0000-0002-5888-3008)
- Daniel H. Wiznia (ORCID: https://orcid.org/0000-0003-3987-0364)
- Ilda Molloy
Institutions
- Yale University (US)
Publication Details
- Journal
- Clinical Orthopaedics and Related Research
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1097/corr.0000000000003402
- Citations
- 4
- Primary Topic
- Orthopedic Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.03